| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | UNI - EN REPORT No | 35 | / | 2016 | | | |
| | Date of issue: | 2016-04-05 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Sopharma monthly March 2016 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | Sopharma AD notifies that for March 2016 the Company recorded a decrease of sales revenues of 19% compared to the same month of 2015, including 17% increase of domestic sales and 36% decrease of export sales.
For the first three months of this year, revenues from sales increased by 2% compared to the same period of 2015, including 8% increase of domestic sales and a 1% decrease of export sales.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | | Sopharma monthly March 2016 | |
+0,17% +0,74gr
-0,30% -1,19gr
